To Predict Heart Disease, Blood Tests Should Check Levels of C-Reactive Protein and Lipoprotein(a) as well as LDL Cholesterol

Simple lab tests that look for two types of fat in the bloodstream and a protein linked to inflammation can help predict a woman’s risk of heart disease up to three decades into the future, a new study published in The New England Journal of Medicine suggests.

Doctors have long used tests of low-density lipoprotein (LDL) cholesterol ( the “bad” cholesterol that can lead to blood clots and heart attacks) to assess heart disease risk.

For the new study, researchers wanted to see if testing for two additional things — a type of fat in the bloodstream known as lipoprotein(a) and a marker of inflammation called C-reactive protein — might provide a more accurate picture of long-term heart health.

To find out, researchers collected blood samples and detailed medical information from about 28,000 women when they were in their mid-fifties, then followed them for 30 years. During the study period, over 3,500 participants had a heart attack, stroke, surgery to restore circulation, or died of cardiovascular-related causes.

Women with the highest levels of LDL cholesterol were 36 percent more likely to experience these cardiovascular events than participants with the lowest LDL levels. Similarly, the risk of these events was increased by 33 percent for women with the highest lipoprotein(a) levels.